<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the role of <z:chebi fb="0" ids="49662">indomethacin</z:chebi> in discriminating between <z:e sem="disease" ids="C0022876" disease_type="Disease or Syndrome" abbrv="">preterm labour</z:e> and cervical insufficiency-related cervical shortening </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Retrospective analysis of <z:hpo ids='HP_0000001'>all</z:hpo> cases of cervical shortening on singleton gestations </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were treated according to our protocol with one or more of the following three modalities: (1) bed rest only, (2) bed rest and <z:chebi fb="0" ids="49662">indomethacin</z:chebi> and (3) cervical cerclage, bed rest, and <z:chebi fb="0" ids="49662">indomethacin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Outcomes: foetal loss &lt;24 weeks, birth weight, delivery &lt;34 weeks, and delivery &lt;37 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We treated 342 patients: 167 (48.8%) with bed rest only, 21 (6.1%) with cerclage, and 154 (45.1%) with <z:chebi fb="0" ids="49662">indomethacin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>By 28 weeks 56 (16.3%) remained stable or improved with bed rest only, 91 (26.6%) failed <z:chebi fb="0" ids="49662">indomethacin</z:chebi> and required cerclage, and the remaining 173 (50.6%) responded well to <z:chebi fb="0" ids="49662">indomethacin</z:chebi> and <z:chebi fb="1" ids="7565">nifedipine</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Birth weight was 3119 g ± 651 (SD) and GA at delivery 37.4 weeks ± 2.5 (SD) </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 342 patients, 4 (1.2%) aborted &lt;24 weeks, 1 was terminated (<z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>), 320 (93.6%) patients delivered &gt;34 weeks and 301 (88.1%) &gt;37 weeks </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Use of <z:chebi fb="0" ids="49662">indomethacin</z:chebi> in patients with cervical shortening discriminates patients with cervical insufficiency from those in <z:e sem="disease" ids="C0022876" disease_type="Disease or Syndrome" abbrv="">premature labour</z:e> and improves outcomes in comparison to existing published reports </plain></SENT>
</text></document>